Pfizer Pharmaceuticals LLC

Form 483 issued January 26, 2018 · Vega Baja, Puerto Rico

Inspection
Jan 10 – Jan 26, 2018
Observations
1
Pages
3
FEI number
2623619

In short: On January 26, 2018, FDA issued a Form 483 with 1 observation to Pfizer Pharmaceuticals LLC in Vega Baja, Puerto Rico (FEI 2623619) after an inspection that ran Jan 10 – Jan 26, 2018. The investigators were Jose Velez and Marian E. Ramirez. Most observations concern quality system; the most-cited regulation is 21 CFR 211.192 (production record review).

At a glance

1 of 1 observations on this 483 concern quality system.

Quality system1

Most cited: 21 CFR 211.192 (1×)

What FDA observed

Preview: the opening words of each observation
  1. 01

    There is a failure to thoroughly review any unexplained discrepancy whether or not the batch…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Pfizer Pharmaceuticals LLC?

FDA listed 1 observation on this Form 483, mostly about quality system. The most-cited regulation is 21 CFR 211.192 (production record review). The opening words of each observation are shown on this page.

Who inspected Pfizer Pharmaceuticals LLC?

Jose Velez and Marian E. Ramirez are named on this Form 483, for the inspection of Jan 10 – Jan 26, 2018. Each investigator has a profile showing what they cite most.

When was Pfizer Pharmaceuticals LLC inspected by FDA?

The inspection ran Jan 10 – Jan 26, 2018, and the Form 483 is dated January 26, 2018.

How do I get the full Form 483 for Pfizer Pharmaceuticals LLC?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free